The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
And the same thing. things that come up as being difficult and controversial in any screening, you know, whether it's prostate cancer screening, breast cancer screening, any of these screening areas are going to be super controversial here. But I think the community agrees mostly that screening angiography is not appropriate.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
But I think the community agrees mostly that screening angiography is not appropriate.